These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 16197789

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA.
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
    Emery MG, Fisher JM, Chien JY, Kharasch ED, Dellinger EP, Kowdley KV, Thummel KE.
    Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
    Clark JM, Alkhuraishi AR, Solga SF, Alli P, Diehl AM, Magnuson TH.
    Obes Res; 2005 Jul; 13(7):1180-6. PubMed ID: 16076987
    [Abstract] [Full Text] [Related]

  • 8. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.
    Mottin CC, Moretto M, Padoin AV, Kupski C, Swarowsky AM, Glock L, Duval V, da Silva JB.
    Obes Surg; 2005 Jul; 15(6):788-93. PubMed ID: 15978148
    [Abstract] [Full Text] [Related]

  • 9. Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery.
    Srivastava S, Younossi ZM.
    Hepatology; 2005 Aug; 42(2):490-2. PubMed ID: 15977205
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA, Kunde SS, Lazenby AJ, Clements RH.
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS, Helzberg JH, Nachnani JS, Gurram K.
    Surg Obes Relat Dis; 2008 Aug; 4(5):612-7. PubMed ID: 18226970
    [Abstract] [Full Text] [Related]

  • 17. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
    Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannagé-Yared MH, Bedossa P, Paradis V.
    Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
    [Abstract] [Full Text] [Related]

  • 18. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
    Keshishian A, Zahriya K, Willes EB.
    Obes Surg; 2005 Jun; 15(10):1418-23. PubMed ID: 16354521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis.
    Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, Simard S, Marceau P.
    Surgery; 2004 Jan; 135(1):48-58. PubMed ID: 14694300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.